Evaluation of the Fetal MPI in Abnormal Cardiotocography Cases in 3rd Trimester of Pregnancy and Fetal Outcome.
NCT ID: NCT03638245
Last Updated: 2018-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
148 participants
OBSERVATIONAL
2018-10-10
2020-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Modified Myocardial Performance Index and Epicardial Thickness in Cases With Idiopathic Polyhydramnios
NCT05737043
Echocardiographic Assessment of Ventricular Strain During a Healthy Pregnancy in the First, Second, and Third Trimester.
NCT04395014
Cardiac Performance in Pregnant Obese Women:Are They in Jeopardy?
NCT02436343
The Right Heart During and After Pregnancy - an Echocardiographic Study
NCT03402971
Transthoracic Echocardiography of Ventricular Function of Parturients in Labor
NCT04481503
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Hypothesis:
In women with non reassuring fetal cardiotocography, myocardial performance index may predict fetal distress accurately.
Study Question:
In pregnant women in the third trimester with abnormal cardiotocography, Does myocardial performance index predict fetal distress accurately?
Study Objectives:
This study aims to assess the accuracy of myocardial performance index in predicting fetal distress in pregnant women with non reassuring cardiotocography in third trimester.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abnormal CTG
This group includes pregnancies that showed abnormalities in CTG.
No interventions assigned to this group
Normal CTG
This group includes pregnancies that showed no abnormalities in CTG.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Women pregnant in singleton fetus.
Exclusion Criteria
2. Fetal congenital malformation.
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ali Mohamed AbdEl-Halim Ali Mehanna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ali Mohamed AbdEl-Halim Ali Mehanna
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed H Nasr El din, MD
Role: STUDY_CHAIR
Professor
Amr MA El Helaly, MD
Role: STUDY_DIRECTOR
Assistant Professor
Noha AA Sakna, MD
Role: STUDY_DIRECTOR
Lecturer
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USCU 230
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.